vancomycin has been researched along with Gallbladder Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayraktar, M; Ozgönül, A; Tekin Koruk, S; Tümer, S | 1 |
| Garrett, DO; Hill, B; Jarvis, WR; Jochimsen, E; Johnston, J; McAllister, S; Murfitt, K; Nelson, P; Sall, RK; Spera, RV; Tenover, FC; Zimmer, B | 1 |
2 other study(ies) available for vancomycin and Gallbladder Neoplasms
| Article | Year |
|---|---|
[Post-operative bacteremia caused by multidrug-resistant Aerococcus viridans in a patient with gall bladder cancer].
Topics: Aerococcus; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Multiple, Bacterial; Gallbladder Neoplasms; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Vancomycin | 2010 |
The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Microbial; Fatal Outcome; Female; Gallbladder Neoplasms; Humans; Microbial Sensitivity Tests; Middle Aged; Nasal Mucosa; Personnel, Hospital; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1999 |